Skip to content
10-K

Annual Report

Arcadia Biosciences, Inc. RKDA

0001193125-26-126238

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 19, 2026 2.06M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.37M sh
Shares Diluted FY 2025 · Dec 31, 2024 1.36M sh
Capex FY 2025 · Dec 31, 2025 $0
Capex FY 2025 · Dec 31, 2024 $16K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$4.74M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$9.63M
Short Term Investments FY 2025 · Dec 31, 2025 $4.3M
Short Term Investments FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $259K
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.24M
Current Liabilities FY 2025 · Dec 31, 2025 $2.06M
Current Liabilities FY 2025 · Dec 31, 2024 $2.56M
Total Liabilities FY 2025 · Dec 31, 2025 $2.41M
Total Liabilities FY 2025 · Dec 31, 2024 $7.29M
Current Assets FY 2025 · Dec 31, 2025 $6.36M
Current Assets FY 2025 · Dec 31, 2024 $9.24M
Total Assets FY 2025 · Dec 31, 2025 $6.55M
Total Assets FY 2025 · Dec 31, 2024 $13.52M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.71
Eps Diluted FY 2025 · Dec 31, 2024 −$5.17
Eps Basic FY 2025 · Dec 31, 2025 −$1.71
Eps Basic FY 2025 · Dec 31, 2024 −$5.17
Sga Expense FY 2025 · Dec 31, 2025 $7M
Sga Expense FY 2025 · Dec 31, 2024 $9.64M
Rd Expense FY 2025 · Dec 31, 2025 $9K
Rd Expense FY 2025 · Dec 31, 2024 $53K
Net Income FY 2025 · Dec 31, 2025 −$2.34M
Net Income FY 2025 · Dec 31, 2024 −$7.04M
Operating Income FY 2025 · Dec 31, 2025 −$2.5M
Operating Income FY 2025 · Dec 31, 2024 −$3.65M
Cost Of Revenue FY 2025 · Dec 31, 2025 $3.1M
Cost Of Revenue FY 2025 · Dec 31, 2024 $2.96M
Revenue FY 2025 · Dec 31, 2025 $4.86M
Revenue FY 2025 · Dec 31, 2024 $5.05M